Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL4674 Target Snapshot

Mitogen-activated protein kinase 12 · SINGLE PROTEIN · Homo sapiens

2,140Compounds
430Assays
2Approved Drugs
1,221.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt P53778. Use UniProt P53778 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P53778 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Mitogen-activated protein kinase 12 as ChEMBL target CHEMBL4674, mapped to UniProt P53778. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Mitogen-activated protein kinase 12
SINGLE PROTEIN · Homo sapiens
As of 2026-09-13
ChEMBL target ID
CHEMBL4674
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
P53778
Mitogen-activated protein kinase 12
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Mitogen-activated protein kinase 12 is the right protein anchor across sources, using UniProt P53778 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMitogen-activated protein kinase 12
UniProt AccessionP53778
Component TypeProtein
Sequence Length367 aa

Mitogen-activated protein kinase 12

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Mitogen-activated protein kinase 12, mapped to UniProt P53778. Sequence length is 367 aa.

Mapped IDP53778
Review nameMitogen-activated protein kinase 12
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

2
Approved
2
Phase III
9
Phase II
3
Phase I
Assay Mix

Activity Type Distribution

IC50319.0
KI749.0
KD153.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL103667 8.54 Kd 2.9 Clinical
CHEMBL5808926 8.3 IC50 5.0 Preclinical
CHEMBL3695569 8.3 Kd 5.0 Preclinical
CHEMBL6052957 8.05 IC50 9.0 Preclinical
CHEMBL5197888 8.0 IC50 10.0 Preclinical
CHEMBL5988627 8.0 IC50 10.0 Preclinical
CHEMBL5822857 7.96 IC50 11.0 Preclinical
CHEMBL5831636 7.96 IC50 11.0 Preclinical
CHEMBL6001529 7.89 IC50 13.0 Preclinical
CHEMBL5184542 7.8 IC50 16.0 Preclinical
Distribution

pChEMBL Value Distribution

56
5.0
59
5.5
75
6.0
62
6.5
40
7.0
22
7.5
7
8.0
1
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

430
Total Assays
144
Tested Compounds
3
Assay Types
Binding — 427 assays, 144 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 346 136 6.6
assay format 59 6 6.7
cell-based format 14 2 6.0
subcellular format 8 0
Functional — 2 assays, 108 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 2 108 5.8
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine